Co-morbidity of personality disorder in schizophrenia among psychiatric outpatients in China: data from epidemiologic survey in a clinical population by YanYan Wei et al.
RESEARCH ARTICLE Open Access
Co-morbidity of personality disorder
in schizophrenia among psychiatric
outpatients in China: data from
epidemiologic survey in a clinical
population
YanYan Wei1,2†, TianHong Zhang2†, Annabelle Chow3, YingYing Tang2, LiHua Xu2, YunFei Dai2, XiaoHua Liu2,
Tong Su1, Xiao Pan1, Yi Cui1, ZiQiang Li1, KaiDa Jiang2, ZePing Xiao2, YunXiang Tang1* and JiJun Wang2,4*
Abstract
Background: The reported rates of personality disorder (PD) in subjects with schizophrenia (SZ) are quite varied
across different countries, and less is known about the heterogeneity of PD among subjects with SZ. We examined
the co-morbidity of PD among patients who are in the stable phase of SZ.
Method: 850 subjects were randomly sampled from patients diagnosed with SZ in psychiatric and psycho-counseling
clinics at Shanghai Mental Health Center. Co-morbidity of PDs was assessed through preliminary screening and patients
were administered several modules of the SCID-II. Evidence of heterogeneity was evaluated by comparing patients
diagnosed with SZ with those who presented with either affective disorder or neurosis (ADN).
Results: 204 outpatients (24.0 %) in the stable phase of SZ met criteria for at least one type of DSM-IV PD. There was a
higher prevalence of Cluster-A (odd and eccentric PD) and C (anxious and panic PD) PDs in SZ (around 12.0 %). The most
prevalent PD was the paranoid subtype (7.65 %). Subjects with SZ were significantly more likely to have schizotypal PD
(4.4 % vs. 2.1 %, p = 0.003) and paranoid PD (7.6 % vs. 5.4 %, p = 0.034), but much less likely to have borderline,
obsessive-compulsive, depressive, narcissistic and histrionic PD.
Conclusions: These findings suggest that DSM-IV PD is common in patients with SZ than in the general population.
Patterns of co-morbidity with PDs in SZ are different from ADN.
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Background
There is a close relationship between personality disorder
(PD) and schizophrenia (SZ). This relationship is supported
by epidemiological, phenomenologic, and biologic studies
[1–6]. However, patients with SZ do not appear to adhere
to the normative pattern of co-morbidity. Research has
supported the presence of co-morbidity of PD traits in sub-
jects with SZ [7–9]. The presence of SZ traits may poten-
tially have enormous impacts on a PD assessment. Despite
the prevalence of co-morbidities in SZ, there is a relative
dearth of information in the current literature of Chinese
population. Moreover, estimates of the prevalence of PD
are quite varied across epidemiological surveys in different
countries. This ranges between 4.5 % and 100 % [10–12]
among patients with SZ and other psychotic disorders.
Furthermore, former investigations present with limita-
tions that may affect a comprehensive understanding of
the rates of PD in patients with SZ. The epidemiological
survey in this population in the past 2 decades showed no
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persuasive evidence of the co-morbidity between SZ and
PD. This is in part due to inadequate sample sizes and
non-representation of target sample. The demographic and
clinical profiles could be a critical component in deciding
whether there is difference on PD prevalence rates. Several
previous studies contained mixed samples (e.g. including
schizoaffective disorder and other forms of psychoses).
Sample sizes were also generally small, and lacked the in-
clusion of various clusters and subtypes of PD. Hence it
calls for further investigation to address the question of
prevalence of PD in SZ.
Both PD and SZ are chronic and debilitating mental
disorders. Hence, it is important to collect epidemiological
data on the co-morbidity of PD and SZ [13–16]. This data
will have practical implications for practicing clinicians
[15, 17]. A recent study indicated that co-morbid Border-
line PD has a significant negative longitudinal impact on
the course and outcome of patients with SZ [18]. Examin-
ing PD in SZ patients will also help us understand the
"schizophrenic spectrum" concept, which includes group
disorders like SZ and Cluster A PDs (i.e. schizotypal,
schizoid, and paranoid PD) that could be genetically
inherited [19–21]. As mentioned in previous studies, some
PDs traits may be an independent risk syndrome for
psychosis [22, 23]. Hence, it is important to identify a pos-
sible range of pre-morbid PDs that may occur as part of
the prodromal phase of SZ that addresses both symptoms
and risks for future psychosis.
It has been recognised that pathological personality
occurs in the context of SZ both before and after the onset
of psychosis. Hence, several papers put forward the notion
that some pre-morbid subtypes of PD (such as schizotypal
PD) may be more vulnerable to SZ, and as a result, affect
the prognosis of SZ. There is an abundance of evidence
that supports the high co-morbidity rate between PD and
affective or anxiety disorders [24–27]. Yet, compared to
other mental disorders, literature on the co-morbidity of
PD with SZ is significantly lesser. It appears that clinicians
in China also tend to pay less attention to a co-morbid PD
diagnosis with patients with SZ.
There are no existing reports on the prevalence of PD in
Chinese patients with SZ. Even in the Chinese literature,
related data of pathological personality in SZ are rare.
Because diagnosis of PD in China adheres to the CCMD-3
standards (Chinese Classification and Diagnostic Criteria of
Mental Disorders, Third Edition), other mental disorders
recognised by the DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, 4th Edition) are excluded.
As a result, the co-morbidity of PDs in SZ in China re-
mains largely unknown. The results of PD rates vary in dif-
ferent countries. For example, the Canadians and Swedish
were less likely to meet a diagnosis of PD in the psychotic
population compared to the Spanish patients [11, 28]. The
diagnosis of PD may be influenced by cultural and social
backgrounds. The Chinese grew up under the strong influ-
ence of traditional eastern values while facing rapid
changes in the social structure. This has, no doubt, a broad
range of impacts on the Chinese community, and hence is
worth exploring this phenomenon.
The primary objective of the present study is to examine
the distribution of PDs in Chinese patients with SZ. To the
best of our knowledge, this is the first study that examines
the prevalence of DSM-IV PD using a large clinical sample
with SZ in China. It is also an examination of the extent of
PD-SZ co-morbidity using DSM diagnoses compared to
those with affective disorder or neurosis (ADN). A few
hypotheses (such as the pre-morbid model for spectrum
hypothesis and the post-morbid model for scar hypothesis)
were tested in efforts to enhance our understanding of their
inter-relations and differences. In addition, the current
study is the first to discuss the feasibility and necessity in
carrying out possible comprehensive interventions on
pathological personality in SZ population.
Method
Subjects
The epidemiologic survey on PD in clinical settings was
conducted in 2006 in Shanghai [29–33]. As detailed else-
where [30], the participants were recruited from the largest
psycho-counseling and psychiatric clinics in Shanghai. Two
staff members issued invitation letter to the one-tenth out-
patient in psycho-counseling and one-twentieth outpatient
in psychiatric clinics according to hospital registration list.
Thus, in total of 3402 subjects were randomly sampled
from the mental health service setting. During the prelimin-
arily screening process, 327 ineligible outpatients were
excluded according to the inclusion and exclusion criteria.
After obtaining the patients' informed consent, 3075
subjects were included in the study, and screened with a
self-reported questionnaire (the Personality Diagnostic
Questionnaire, PDQ-4+). Subsequently, 2590 participants
who screened positive were referred for a face-to-face inter-
view (Structured Clinical Interview for DSM-IV AxisII,
SCID-II). The CCMD-3 diagnoses were collected according
to outpatients’ medical records.
For this paper, we obtained data on a selected sample of
outpatients with SZ. About 951 outpatients (30.9 %) were
diagnosed with SZ or other psychotic disorders according
to their medical records. To ensure that selection is only
limited in SZ, clinicians were asked to check the patients’
medical records. 101 subjects (10.6 %) were then excluded
because their diagnosis was unclear or other psychotic
disorders (such as paranoid psychosis, acute transient
psychosis, traveling psychosis et al.).
Consequently, the remaining 850 subjects with SZ
who were recruited from the previous epidemiological
survey between May and October 2006 were analyzed.
Amongst them were 184 subjects (21.6 %) from the psycho-
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counseling clinic and 666 subjects (78.4 %) from the psychi-
atric clinic. There were 371 males (43.6 %) and 479 females
(56.4 %). The average age was 31.7 years (SD = 9.8). The
average course was 85.2 months (SD= 95.8) within the
range of 1–480 month. 543 participants (63.9 %) were single,
238 (28.0 %) were married, 54 (6.4) were divorced, 15
(1.8 %) were widowhood; 323 (38.0 %) completed col-
lege or higher; while 453 (53.3 %) participants earned
less than 1000 Yuan a month.
From these 3075 subjects, 1403 outpatients who were
diagnosed with affective disorder or neurosis (ADN) were
selected as the control group. They were identified through
their medical records. Amongst those outpatients, there
were 605 males and 798 females, with a mean age of
32.6 years (SD = 10.2, ranged 18–60 years). 742 subjects
with mood disorders (including bipolar disorder and de-
pression), 661 subjects with neurosis (including anxiety
disorders (N = 517) such as phobia, panic disorder, general-
ized anxiety disorder, obsessive-compulsive disorder, and
somatoform disorders (N = 144) such as somatization dis-
order, hypochondriasis, neurasthenia).
Assessment tools of personality disorders and procedures
The Research Ethics Committee at the Shanghai Mental
Health Centre approved the study in 2006. All partici-
pants were given detailed explanation about the study,
including a plain language statement written in their
native language. Their written informed consent was ob-
tained before recruited for the study. Only participants
of the clinic who were judged to be fully competent to
give informed consent for participation were included.
An independent senior psychiatric nurse judged if the
individual with SZ was competent in giving informed
consent. Participation could be withdrawn at any time,
and non-participation in the research would not affect
the quality of clinical care.
PD assessments were administered using the Personal-
ity Diagnostic Questionnaire (PDQ-4+) and Structured
Clinical Interview for DSM-IV AxisII(SCID-II)[30]. Both
correspond to the criteria of DSM-IV PD. The SCID-II
is a semi-structured clinical interview for PD diagnosis.
It contains 12 subscales corresponding to the 12 Axis II
DSM-IV PDs, which comprise Cluster A PD (Paranoid,
Schizoid, Schizotypal PD), Cluster B PD (Histrionic, Nar-
cissistic, Borderline, Antisocial PD), Cluster C PD (Avoidant,
Dependent, Obsessive-compulsive PD), Passive-aggressive
PD and Depressive PD (in the appendix of DSM-IV). The
sample was selected using a two-stage probability sample
design. At the first stage, all the eligible subjects was
screened by PDQ-4+, which conducted by three senior
nurses. At the second stage, patients whose PDQ-4+ score
met some form of PD subsequently attended the SCID-II
interview by two trained psychiatrists. The Chinese version
of SCID-II was previously translated and adapted by the
research team members [34].
PDQ-4+ screening questions were administered to 850
subjects with SZ. PDQ-4+ has been widely used to screen
for DSM-IV PD. Although specificity is medium, it is a
relatively sensitive (0.89) test. 523 subjects whose PDQ-4+
test result was positive were interviewed with the SCID-II.
The diagnosis of PDs requires evaluation of long-term
patterns of functioning. Hence that implies that there is a
potential for state effects. Subjects were asked to reflect
and discuss about “everyday life” rather than “recent situa-
tions” during PD assessments.
Diagnosis of Schizophrenia and other Axis I disorder
CCMD-3 (the Chinese Classification of Mental Disor-
ders) is substantially influenced by ICD-10 and DSM-IV
representations. The uniaxial classification system used
in CCMD gave little thought to issues of co-occurring
PDs with other disorders. Most of the diagnostic criteria
of SZ are identical to international classifications. How-
ever, there is a major difference between the CCMD-3
and DSM systems in the diagnosis of SZ; the duration
criterion for SZ is 1 month in CCMD-3, but 6 months
in DSM-IV.
Subjects with ADN were considered as a control group
because overwhelming clinical evidence showed that de-
pression and neurosis frequently coexist in the same indi-
vidual, either concurrently or at different times. Therefore,
it is hard to distinguish mood and neurosis in detail. This
group is also highly heterogeneous with SZ group. Differ-
ences include clinical characteristics, presence of predis-
posing personality, social factors, and the preservation of
insight. Amongst the patients in psychiatric clinics and
psycho-counseling clinics, SZ, affective disorders and
neurosis made up the majority (making up nearly 3/4 of
the total sample in 2006).
Statistical analysis
All analyses presented were conducted for the sample
with SZ and have used ADN as the comparative group.
Frequencies and 95 % confidence interval (95 % CI) of
PDs, in accordance to PDQ-4+ and SCID-II were calcu-
lated by cluster and specific PD. These comparisons
assessed for unadjusted differences by age, sex, educa-
tion and marriage state, proportions of patients visiting
psycho-counseling or psychiatric clinic, self-reported
characteristics and course. Odds ratios (OR) were gen-
erated to assess associations of PD with those socio-
demographic characteristics. Before applying paramet-
ric statistics, all variables were checked the normality of
the scores distribution.
Two tailed t-tests were used to compare PDQ-4+
mean scores of patients with SZ and ADN by cluster
and specific PD. Chi-squared tests were used to compare
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the proportions of PD patients according to SCID-II. All
statistical differences were considered significant at P <
0.05. Stepwise regression modeling was used to assess
the impact of PD on a mental disorder diagnosis. The
presence of SZ was entered as the dependant variable
and age, sex and the presence of PD were entered as the
independent variables. OR, 95 % CI, χ2 statistic and p




When the self-rating tool of PDQ-4+ was used for
described the feature of PDs, the rate of endorsement
of PD traits in our schizophrenics sample with was
relatively high (Table 1). 81.5 % participants presented
with at least one PD traits. The most frequent PD
trait in this sample was avoidant PD (52.6 %),
followed by obsessive-compulsive (48.2 %) and para-
noid PD (39.3 %).
When structured interview tool of SCID-II were used
for PD diagnosis, the frequency of PD among respon-
dents with SZ was also common. Nearly one quarter of
participants meet criteria for at least one DSM-IV PD,
with the most prevalent PD was paranoid PD (7.65 %),
followed by avoidant (7.53 %) and schizotypal (4.35 %)
PD. Cluster A PDs (12.12 %) were the most common
PD types compared to other clusters.
Association with clinical and socio-demographic
characteristics
The overall prevalence of PDs was significantly greater in
younger group than older (OR = 1.969) (Table 2). Subjects
who were single (OR = 1.812), had a greater prevalence
compared to married status. PDs were also significantly
more prevalent in the psycho-counseling clinic (OR =
2.438) than in Psychiatric clinic. The prevalence of PD also
varied across categories of self-reported characteristics
(Introversion, Middle type, Extroversion). PDs were most
prevalent in subjects who had characteristics of Introver-
sion (OR = 1.982). Subjects who had an ill duration of
lesser than 6 months were more prevalent compared to
those with a more chronic presentation, but the odds of
having PD did not differ significantly.
Comparative analyses of personality disturbance
As seen in Table 3, the first set of analyses focused on
the self-reported personality disturbance. Subjects with
SZ reported significantly less symptoms of cluster B and
C PD traits compared to subjects with ADN, except the
dependent PD. The mean score of cluster A PDs of two
groups did not differ significantly. The second set of
analyses was conducted to investigate the difference of
PD prevalence between the SZ and ADN group. Subjects
with SZ were significantly more likely to have schizo-
typal PD (4.4 % vs. 2.1 %, p = 0.003) and paranoid PD
(7.6 % vs. 5.4 %, p = 0.034), but much less likely to have
Table 1 Frequency of DSM-IV PDs among patients with schizophrenia using PDQ-4+ and SCID-II
PDQ-4+ SCID-II
N (%) 95 % CI N (%) 95 % CI
aAny PDs 693 (81.53 %) 78.92 – 84.14 % 204 (24.00 %) 21.13 – 26.87 %
Any Cluster A PD 503 (59.18 %) 55.87 – 62.48 % 103 (12.12 %) 9.92 – 14.31 %
Paranoid PD (PAR) 334 (39.29 %) 36.01 – 42.58 % 65 (7.65 %) 5.86 – 9.43 %
Schizoid PD (SCH) 167 (19.65 %) 16.98 – 22.32 % 20 (2.35 %) 1.33 – 3.37 %
Schizotypal PD (SCHT) 314 (36.94 %) 33.70 – 40.19 % 37 (4.35 %) 2.98 – 5.72 %
Any Cluster B PD 424 (49.88 %) 46.52 – 53.24 % 32 (3.76 %) 2.49 – 5.04 %
Histrionic PD (HIS) 254 (29.88 %) 26.81 – 32.96 % 10 (1.18 %) 0.45 – 1.90 %
Narcissistic PD (NAR) 220 (25.88 %) 22.94 – 28.83 % 9 (1.06 %) 0.37 – 1.75 %
Borderline PD (BOR) 322 (37.88 %) 34.62 – 41.14 % 17 (2.00 %) 1.06 – 2.94 %
Antisocial PD (ANT) 215 (25.29 %) 22.37 – 28.22 % 2 (0.24 %) 0-0.56 %
Any Cluster C PD 580 (68.24 %) 65.11 – 71.37 % 102 (12.00 %) 9.82 – 14.18 %
Avoidant PD (AVO) 447 (52.59 %) 49.23 – 55.95 % 64 (7.53 %) 5.76 – 9.30 %
Dependent PD (DEP) 254 (29.88 %) 26.81 – 32.96 % 29 (3.41 %) 2.19 – 4.63 %
Obsessive-compulsive PD (OBC) 410 (48.24 %) 44.88 – 51.59 % 30 (3.53 %) 2.29 – 4.77 %
In the Appendix of DSM-IV
Passive-aggressive PD (PAG) 292 (34.35 %) 31.16 – 37.55 % 23 (2.71 %) 1.62 – 3.80 %
Depressive PD (DPS) 259 (30.47 %) 27.38 – 33.56 % 44 (5.18 %) 3.69 – 6.67 %
aOnly includes 12 PDs as stated in the DSM-IV, not include PD not otherwise specified (PD NOS)
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borderline, obsessive-compulsive, depressive, narcissistic
and histrionic PD.
Stepwise regression analyses
Stepwise regression was employed in an attempt to
identify the risk factors of PDs related to SZ or ADN.
Logistic regression (forward stepwise) analyses were
performed in the presence of SZ as the dependent
variable while age, gender, different type of PDs acted
as independent variables (Table 4). Among those PDs,
paranoid and schizotypal PD were significant predic-
tors of SZ, and borderline, obsessive-compulsive, de-
pressive, histrionic PDs were significant predictors of
ADN.
Table 2 Odds ratios (and 95 % CI) of having PDs, by clinical and socio-demographic characteristics
Number PD PD (%) 95 % CI OR 95 % CI
Male 371 86 23.2 18.9 ~ 27.5 % 0.923 0.671 - 1.269
Female 479 118 24.6 20.8 ~ 28.5 % 1.083 0.788 – 1.489
~30 Years 439 131 29.8 25.6 ~ 34.1 % 1.969 1.423 – 2.726
30 ~ Years 411 73 17.8 14.1 ~ 21.5 % 0.508 0.367 – 0.703
Middle or high school 527 127 24.1 20.4 ~ 27.8 % 1.014 0.733 – 1.403
College or higher 323 77 23.8 19.2 ~ 28.5 % 0.986 0.713 – 1.364
Single or divorced, widowhood 612 164 26.8 23.3 ~ 30.3 % 1.812 1.234 – 2.660
Married 238 40 16.8 12.1 ~ 21.6 % 0.552 0.376 – 0.810
Psycho-counseling clinic 184 70 38.0 31.0 ~ 45.1 % 2.438 1.713 – 3.469
Psychiatric clinic 666 134 20.1 17.1 ~ 23.2 % 0.410 0.288 – 0.584
Introversion 438 131 29.9 25.6 ~ 34.2 % 1.982 1.431 – 2.743
Middle type 293 53 18.1 13.7 ~ 22.5 % 0.594 0.418 – 0.844
Extroversion 119 20 16.8 10.1 ~ 23.5 % 0.601 0.361 – 0.999
Course < =6 month 151 45 29.8 22.5 ~ 37.1 % 1.442 0.975 – 2.132
Course >6 month 699 159 22.7 19.6 ~ 25.9 % 0.694 0.469 – 1.025
Note: Age grouped by median age of the sample
Table 3 Comparison of difference between SZ and ADN for PDQ-4+ PDs scores and SCID-II PDs frequency
PDQ-4+ SCID-II
SCH ADN t value SCH (%) ADN (%) χ2 value
Any Cluster A PD 9.04 9.04 −0.028a 12.1% 9.6 % 0.054
PAR 2.82 2.97 −1.759 7.6 % 5.4 % 0.034*
SCH 2.39 2.41 -.308a 2.4 % 2.6 % 0.677
SCHT 3.82 3.66 1.648 4.4 % 2.1 % 0.003**
Any Cluster B PD 12.32 13.05 −2.498a* 3.8 % 12.2 % 0.000**
HIS 3.34 3.64 −3.705** 1.2 % 3.0 % 0.005**
NAR 3.10 3.38 −3.084** 1.1% 2.9 % 0.004**
BOR 4.06 4.44 −3.472** 2.0 % 7.6 % 0.000**
ANT 1.82 1.60 3.155** 0.2 % 0.4 % 0.457
Any Cluster C PD 10.60 11.26 −3.105** 12.0 % 21.7 % 0.000**
AVO 3.61 3.89 −3.298** 7.5 % 9.8 % 0.063
DEP 3.32 3.41 -.998 a 3.4 % 3.1 % 0.720
OBC 3.66 3.95 −3.467a ** 3.5 % 10.8 % 0.000**
In the Appendix of DSM-IV
PAG 2.77 2.97 −2.740** 2.7 % 4.2 % 0.065
DPS 3.35 3.89 −5.987** 5.2 % 11.4 % 0.000**
aLevene's Test for Equality of Variances is significant; *p < 0.05; **p < 0.01
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Discussion
SZ has always been considered the most serious mental
illness in China, and usually accompanied with stigma or
fear from the general community. The personality of this
population is indeed difficult to understand and hence,
is often neglected by people around them. Even psychi-
atric professionals only identify with symptoms such as
hallucinations and delusions, and little attention has
been given to the co-occurrence of PDs in the clinical
assessment routine. This study is a groundbreaking survey
of PDs among patients with SZ in the Chinese population.
More than 80 % of subjects presented with at least one PD
trait, and about one quarter of outpatients suffer from at
least one diagnosable PD. Substantial evidence suggests that
PDs influence other mental disorders’ prognosis, hence to a
certain degree, overlook the PD in patients with SZ might
missed the chance of predicting an Axis I prognosis and
treatment response. Consequently, opportunities of a fo-
cused approach to treatment using psychotherapy are lost.
The prevalence of PD was 24.0 % in this Chinese clinical
population with SZ, and was within the range of estimates
(22 - 28 %) found in some previous epidemiologic surveys
[35–37], but not in others [7, 38–40]. Newton-Howes and
colleagues (2008) used the multilevel modeling method
and found that there was great variation in the reported
prevalence of PD in SZ. The multilevel modeling method
identified that the most possible reason for this difference
was that these studies were carried out in different coun-
tries. Other possibilities that may also have contributed to
the discrepancies included sample size, differences in diag-
nostic criteria, assessment instruments, survey designs
and methodologies.
After the SCID-II interview, Cluster A PDs (especially
Paranoid PD) became the most prevalent PD compared
to other PDs. That is, this pattern of PD co-morbidity
may be explained by the spectrum hypothesis. Kraepelin
and Bleuler considered schizophrenia as the worsening
of schizoid features in the early 20th century. In the late
20th-century, Cluster A PDs was considered as SZ
spectrum PDs [41–43]. It is also well known that Cluster
A PDs was more likely to be noticed among relatives of
patients with SZ [44, 45]. In addition, Cluster C PDs
were also very common among those subjects. The find-
ing that self-reported Cluster C PDs pathology (espe-
cially Avoidant and Obsessive-compulsive PD) is more
common in Chinese patients with SZ is also consistent with
the results of previous studies [28, 46]. This may be partly
due to the effects of SZ on personality over time (the scar
hypothesis). The experiences of stigma and social disability
might account for ‘fearful’ group traits. This paper also ana-
lyzed the socio-demographic characteristics of patients with
SZ. Taken as a whole, the factors associated with increased
odds of PD were younger age, non-marriage status (single,
divorced, or widowhood), in psycho-counseling clinic, and
self-reported characteristics of introversion. This was con-
sistent with findings from many prior studies, which identi-
fied that PDs were more prevalent among younger adults
than older adults [47–50]. Although PDs are defined as
stable and enduring patterns in the DSM, many previous
PD surveys proposed that PD traits (especially Borderline
PD traits) remit with age [51, 52]. Thus, from another view-
point, this phenomenon is partly supported the scar hy-
pothesis, which emphasized the influence of the presence
of SZ on the features in personality psychopathology across
the lifespan. Other characteristics might reflect that those
schizophrenic patients with PDs live a solitary life, required
more support and attention from the society, family and
mental health professionals.
When compared to the patients with ADN, we found a
distinct high co-morbidity of ‘eccentric’ group PDs amongst
patients with SZ, while ‘emotional’ and ‘fearful’ group PDs
were less commonly co-morbid. Paranoid and schizotypal
PD seemed to be strongly associated with SZ, but border-
line, obsessive-compulsive, depressive, histrionic PD were
predictive of ADN. The results of this study showed that
PD plays an important role in accurately diagnosing Axis I
disorder. Because this was not a longitudinal study, it was
difficult to determine the relation of consequences to ante-
cedent. Hence, we mainly considered several possibilities
with regard to the different pathological features of PDs
among Axis I disorders: 1) certain cluster of pre-morbid
PD may be earlier expressions of symptomatology in Axis I
disorders; 2) certain cluster of pre-morbid PD may be vul-
nerabilities to SZ or ADN; 3) certain cluster of co-morbid
PD may be the effects of the presence of Axis I disorders
on personality over time.
The pattern of co-morbidity and heterogeneity of PD in
SZ, as reported in this paper, may have several impacts on
clinical practice. For example, it highlights the need for
Chinese psychiatrists to pay attention to the following
points. Firstly, as approximately one quarter of the re-
cruited sample had been diagnosed with PD, detailed PD
assessments and interventions should be considered for
patients with SZ. That information will also be used to
Table 4 Forward stepwise logistic regression for risk factors
predicting the clinical diagnoses
Variable Beta S.E. OR 95 % CI χ2 statistic P value
Age 0.011 0.005 1.011 1.003-1.020 6.335 0.012
PAR −0.958 0.205 0.384 0.257-0.573 21.841 0.000
SCHT −0.705 0.271 0.494 0.291-0.839 6.800 0.009
BOR 1.457 0.284 4.293 2.461-7.491 26.320 0.000
HIS 0.864 0.362 2.373 1.168-4.821 5.704 0.017
OBC 1.307 0.214 3.695 2.427-5.625 37.134 0.000
DPS 0.761 0.186 2.140 1.486-3.082 16.715 0.000
Constant −0.006 0.155 0.994 - 0.002 0.967
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help us to improve the effectiveness and efficacy of the
care provided at mental health service. Secondly, high co-
morbid rates of Cluster A PDs in SZ imply that subjects
who fall in the schizophrenic spectrum PD may be strongly
linked to SZ. Therefore, clinicians need to give attention to
Cluster A PD-oriented therapy in order to minimize the risk
of psychosis and long term sequelae. Lastly, the difference of
comorbid PD between SZ and ADN suggests that there
may be different ways of developing therapeutic alliance
during therapy. Help-seeking behavior and medical resource
utilization may be quite different with personality types.
Therefore, a range of mental health services and social sup-
port may help meet the different needs for prevention and
rehabilitation.
Several methodological limitations must be considered in
regards to this study. The principal limitation of the cross-
sectional design lies in its inability to distinguish between
cause and effect of PD and SZ. The diagnosis of SZ in the
study was made according to CCMD-3, which may then
result in a fundamental difference in results of this sample
with other international studies. PD symptoms, somehow,
are a part of the syndrome of SZ, which may affect the
accuracy of personality assessment. Subjects in this study
were outpatients of the largest mental health service in
Shanghai and therefore, this may introduce selection bias
and reduce the generalizability of our findings to the gen-
eral SZ population (i.e., recruitment from a general psychi-
atric hospital or forensic psychiatric hospital).
Conclusions
Despite these limitations, these data provide an important
step in understanding the rates of PDs among Chinese
patients with SZ, as well as the association between PD
and SZ. Furthermore, it helps in understanding the role of
PD plays in the difference between SZ and ADN. Future
research can consider following up with patients diagnosed
with PD to ascertain how they are capable of acting on or
influencing each other.
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